New technologies in drug metabolism and toxicity screening: organ-to-organ interaction.
作者信息
Bhushan Abhinav, Martucci Nicole J, Usta O Berk, Yarmush Martin L
机构信息
a Department of Biomedical Engineering , Illinois Institute of Technology , Chicago , IL , USA.
b Department of Biomedical Engineering , Binghamton University , Binghamton , NY , USA.
出版信息
Expert Opin Drug Metab Toxicol. 2016 May;12(5):475-7. doi: 10.1517/17425255.2016.1162292. Epub 2016 Mar 21.
Abstract
摘要
相似文献
1
New technologies in drug metabolism and toxicity screening: organ-to-organ interaction.药物代谢与毒性筛选中的新技术：器官间相互作用
Expert Opin Drug Metab Toxicol. 2016 May;12(5):475-7. doi: 10.1517/17425255.2016.1162292. Epub 2016 Mar 21.
2
Drugs in control samples in nonclinical safety studies: a reconsideration.非临床安全性研究中对照样品中的药物：重新审视
Bioanalysis. 2016 May;8(10):1003-7. doi: 10.4155/bio-2016-0066. Epub 2016 Apr 15.
3
Assessing drug safety in human tissues - what are the barriers?评估人体组织中的药物安全性——存在哪些障碍？
Nat Rev Drug Discov. 2015 Aug;14(8):585-7. doi: 10.1038/nrd4662. Epub 2015 Jul 24.
4
Toxicology Strategies for Drug Discovery - Present and Future: Introduction.药物发现的毒理学策略：现状与未来：引言
Chem Res Toxicol. 2016 Apr 18;29(4):437. doi: 10.1021/acs.chemrestox.6b00049.
5
Troubleshooting computational methods in drug discovery.药物发现中的计算方法故障排除
J Pharmacol Toxicol Methods. 2010 Mar-Apr;61(2):67-75. doi: 10.1016/j.vascn.2010.02.005. Epub 2010 Feb 20.
6
The application of in vitro models of drug metabolism and toxicity in drug discovery and drug development.药物代谢与毒性的体外模型在药物发现和药物开发中的应用。
Drug Chem Toxicol. 1995 Feb;18(1):1-28. doi: 10.3109/01480549509017855.
7
Assessment of drug metabolites.药物代谢物的评估。
Drug Metab Pharmacokinet. 2011;26(2):121-2. doi: 10.2133/dmpk.dmpk-11-pf-902.
8
De-risking drug discovery with ADDME -- avoiding drug development mistakes early.利用 ADDME 降低药物发现风险——尽早避免药物开发错误。
Altern Lab Anim. 2009 Sep;37 Suppl 1:47-55. doi: 10.1177/026119290903701S10.
9
Microphysiological Systems ("Organs-on-Chips") for Drug Efficacy and Toxicity Testing.用于药物疗效和毒性测试的微生理系统（“芯片器官”）
Clin Transl Sci. 2017 Jul;10(4):237-239. doi: 10.1111/cts.12444. Epub 2017 Mar 7.
10
Perspective of humanized mouse models for assessing PK/PD and toxic profile of drug candidates in preclinical study.用于在临床前研究中评估候选药物的药代动力学/药效学及毒性特征的人源化小鼠模型的前景。
Drug Metab Pharmacokinet. 2014;29(1):1-2.
引用本文的文献
1
DNA Nanostructures for Rational Regulation of Cellular Organelles.用于合理调控细胞器的DNA纳米结构
JACS Au. 2025 Mar 26;5(4):1591-1616. doi: 10.1021/jacsau.5c00117. eCollection 2025 Apr 28.
2
Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction.基于整合等基因人类诱导多能干细胞的肝脏和心脏微生理系统预测不安全的药物相互作用。
Front Pharmacol. 2021 May 7;12:667010. doi: 10.3389/fphar.2021.667010. eCollection 2021.
3
Modeling Pharmacokinetic Profiles for Assessment of Anti-Cancer Drug on a Microfluidic System.用于在微流控系统上评估抗癌药物的药代动力学特征建模
Micromachines (Basel). 2020 May 29;11(6):551. doi: 10.3390/mi11060551.
4
Robotic fluidic coupling and interrogation of multiple vascularized organ chips.机器人流控耦合与多个血管化器官芯片的检测
Nat Biomed Eng. 2020 Apr;4(4):407-420. doi: 10.1038/s41551-019-0497-x. Epub 2020 Jan 27.
5
Drug absorption related nephrotoxicity assessment on an intestine-kidney chip.基于肠-肾芯片的药物吸收相关肾毒性评估
Biomicrofluidics. 2017 Jun 1;11(3):034114. doi: 10.1063/1.4984768. eCollection 2017 May.
本文引用的文献
1
A novel low-volume two-chamber microfabricated platform for evaluating drug metabolism and toxicity.一种用于评估药物代谢和毒性的新型小体积双腔微制造平台。
Technology (Singap World Sci). 2015 Dec;3(4):155-162. doi: 10.1142/S2339547815200034. Epub 2015 Apr 21.
2
Current status of pluripotent stem cells: moving the first therapies to the clinic.多能干细胞的现状：将首批疗法推向临床。
Nat Rev Drug Discov. 2015 Oct;14(10):681-92. doi: 10.1038/nrd4738. Epub 2015 Sep 22.
3
A comparison between genetically humanized and chimeric liver humanized mouse models for studies in drug metabolism and toxicity.用于药物代谢和毒性研究的基因人源化和嵌合肝人源化小鼠模型之间的比较。
Drug Discov Today. 2016 Feb;21(2):250-63. doi: 10.1016/j.drudis.2015.09.002. Epub 2015 Sep 7.
4
A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents.一种用于人肠道、肝脏、皮肤和肾脏等效物相互连接的长期共培养的四器官芯片。
Lab Chip. 2015 Jun 21;15(12):2688-99. doi: 10.1039/c5lc00392j.
5
Chip-based human liver-intestine and liver-skin co-cultures--A first step toward systemic repeated dose substance testing in vitro.基于芯片的人肝-肠和肝-皮肤共培养——体外系统性重复剂量物质测试的第一步。
Eur J Pharm Biopharm. 2015 Sep;95(Pt A):77-87. doi: 10.1016/j.ejpb.2015.03.002. Epub 2015 Apr 6.
6
Organs-on-chips at the frontiers of drug discovery.药物研发前沿的器官芯片
Nat Rev Drug Discov. 2015 Apr;14(4):248-60. doi: 10.1038/nrd4539. Epub 2015 Mar 20.
7
Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.在含有诱导多能干细胞衍生的人肝细胞的微图案共培养体系中对药物性肝损伤的预测
Toxicol Sci. 2015 Jun;145(2):252-62. doi: 10.1093/toxsci/kfv048. Epub 2015 Feb 24.
8
A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing.用于长期物质测试的神经球与肝脏等效物的多器官芯片共培养。
J Biotechnol. 2015 Jul 10;205:36-46. doi: 10.1016/j.jbiotec.2015.02.002. Epub 2015 Feb 9.
9
Chimeric TK-NOG mice: a predictive model for cholestatic human liver toxicity.嵌合型TK-NOG小鼠：一种用于预测人类胆汁淤积性肝毒性的模型。
J Pharmacol Exp Ther. 2015 Feb;352(2):274-80. doi: 10.1124/jpet.114.220798. Epub 2014 Nov 25.
10
Fialuridine induces acute liver failure in chimeric TK-NOG mice: a model for detecting hepatic drug toxicity prior to human testing.法昔洛韦诱导嵌合 TK-NOG 小鼠发生急性肝衰竭：在人体试验前检测肝脏药物毒性的模型。
PLoS Med. 2014 Apr 15;11(4):e1001628. doi: 10.1371/journal.pmed.1001628. eCollection 2014 Apr.
Zotero 插件